Editas Medicine, Inc.
EDIT· Nasdaq
EDITEditas Medicine, Inc.
Filed Aug 9, 2017 · 10-Q · 40 days after period end · 0001558370-17-006422
| Metric | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|
| Revenue | $3.10M | — | — |
| Net Income | -$26.44M | -$19.04M | -$47.57M |
| EPS Diluted | -$0.65 | -$0.54 | -$21.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Editas Medicine, Inc. · CIK 1650664 · Engraved from SEC EDGAR
ended Jun 30, 2017 · filed Aug 9, 2017 · 40 d after period end
